Suppr超能文献

来自准噶尔阿魏的Conferone通过竞争性抑制P-糖蛋白转运增强长春碱对MDCK-MDR1细胞的细胞毒性。

Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.

作者信息

Barthomeuf Chantal, Demeule Michel, Grassi Jérôme, Saidkhodjaev Ashraf, Beliveau Richard

机构信息

UMR: INSERM U-484, Université d'Auvergne, Centre hospitalier J. Perrin, Laboratoire de Pharmacognosie et de Biotechnologie, Faculté de Pharmacie, Clermont-Ferrand, France.

出版信息

Planta Med. 2006 Jun;72(7):634-9. doi: 10.1055/s-2006-931574. Epub 2006 May 31.

Abstract

Overexpression of the protein transporter P-glycoprotein (Pgp, MDR1) at the cell surface is a major cause of multidrug resistance (MDR) and poor response to treatment in cancer chemotherapy and therapy for leishmaniasis. The present study shows that conferone, a sesquiterpene coumarin ether isolated for the first time from Ferula schtschurowskiana, endemic in Uzbekistan, enhances the cell toxicity of vinblastine (VBL) in MDR1-transfected Madin-Darby canine kidney (MDCK-MDR1) cells. Conferone presents the advantage to mediate this effect at safe concentrations. At 10 microM, it efficiently competes with the photoactivatable cyclosporin A analogue (SDZ 212 - 122) for the binding to Pgp and accumulates [3H]-VBL to a higher extent than cyclosporin A or cnidiadin. [3H]-VBL accumulation is dose-dependent and correlates with the inhibition of Pgp photolabeling affinity, supporting the hypothesis that conferone sensitizes MDCK-MDR1 cells to VBL by competitively inhibiting drug efflux. In MDCK-MDR1 cells, [3H]-VBL accumulation appears to be almost completely dependent on inhibition of Pgp transport. However, the strict specificity of conferone to this efflux pump has to be demonstrated in cell lines expressing other protein transporters. Collectively, our findings identify conferone as a powerful modulator of Pgp transport and a promising molecule for the treatment of MDR malignancies and leishmaniasis. Complementary in vitro and in vivo studies are, however, needed to assess the value of conferone as a reversal drug in human therapy. Considering its high affinity for Pgp, conferone may have an additional usefulness as a tool for the design or the (hemi)synthesis of agents probing Pgp. To our knowledge, this is the first report identifying sesquiterpene coumarins from Ferula as possible drug candidates for the reversion of MDR encoded by the MDR1 gene or the synthesis of agents probing Pgp.

摘要

细胞表面蛋白转运体P-糖蛋白(Pgp,MDR1)的过表达是癌症化疗和利什曼病治疗中多药耐药(MDR)及治疗反应不佳的主要原因。本研究表明,首次从乌兹别克斯坦特有的费尔干纳阿魏中分离出的倍半萜香豆素醚——康弗酮,可增强长春碱(VBL)对转染了MDR1的马-达二氏犬肾(MDCK-MDR1)细胞的细胞毒性。康弗酮具有在安全浓度下介导这种效应的优势。在10微摩尔浓度时,它能有效地与可光活化的环孢菌素A类似物(SDZ 212 - 122)竞争与Pgp的结合,并比环孢菌素A或蛇床子素更有效地积累[3H]-VBL。[3H]-VBL的积累呈剂量依赖性,且与Pgp光标记亲和力的抑制相关,支持了康弗酮通过竞争性抑制药物外排使MDCK-MDR1细胞对VBL敏感的假说。在MDCK-MDR1细胞中,[3H]-VBL的积累似乎几乎完全依赖于对Pgp转运的抑制。然而,康弗酮对这种外排泵的严格特异性必须在表达其他蛋白转运体的细胞系中得到证实。总体而言,我们的研究结果表明康弗酮是Pgp转运的有力调节剂,是治疗MDR恶性肿瘤和利什曼病的有前景的分子。然而,需要进行补充的体外和体内研究来评估康弗酮作为人类治疗中逆转药物的价值。鉴于其对Pgp的高亲和力,康弗酮作为探测Pgp的试剂设计或(半)合成的工具可能还有额外的用途。据我们所知,这是第一份鉴定出阿魏中的倍半萜香豆素可能作为逆转由MDR1基因编码的MDR的候选药物或探测Pgp的试剂合成原料的报告。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验